FindTrial
Sign In

Intraoperative Transesophageal Echocardiac evaluation of Aortic valve

Intraoperative Transesophageal Echocardiographic evaluation of Aortic valve and its comparison with Preoperative Transthoracic Echo in patients posted for Aortic valve replacement.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026810
Enrollment
40
Registered
2020-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I069- Rheumatic aortic valve disease, unspecified

Interventions

None listed

Sponsors

Aseem Gargava
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Any patient posted for aortic valve replacement for severe aortic regurgitation without left ventricular dysfunction requiring transesophageal echocardiographic evaluation.

Exclusion criteria

Exclusion criteria: 1. age less than 18 years 2. ASA IV or more. 3. patients with contraindication for TEE. 4. Midline redo surgeries. 5. Severe or moderate Aortic stenosis. 6. Severe or moderate Mitral stenosis or regurgitation.

Design outcomes

Primary

MeasureTime frame
The primary haemodynamic parameters recommended for clinical evaluation of AR severity: - Regurgitant volume. - Regurgitant fraction. - Effective regurgitant orifice area. - vena contracta width. - Diastolic reversal of flow in descending aorta. Timepoint: Preoperatively using Transthoracic echo and Intraoperatively using Transesophageal echo.—

Secondary

MeasureTime frame
secondary parameters: - hemodynamic parameters during evaluation, - any additional TEE findings. Timepoint: - secondary parameters: - hemodynamic parameters during evaluation, -—

Countries

India

Contacts

Public Contactaseem gargava

Seth GS medical college

aseemgargava@gmail.com9977997812

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026